Tesla stock had an extraordinary run in the last month. Click here to find out why we continue to believe that TSLA stock is ...

NervGen's groundbreaking NVG-291 treatment for spinal cord injury is currently in trials with FDA Fast Track Designation.

The benchmark S&P 500 ( SP500) increased +1.10% to end at 6,040.04 points, while the blue-chip Dow ( DJI) added +0.91% to settle at 43,297.03 points. The tech-heavy Nasdaq Composite ( COMP:IND) surged ...

T. Rowe Price Ultra Short-Term Bond ETF has a 5.3% yield with low volatility and alternative options for minimal ...

We caution investors on Vistra, highlighting overvaluation despite growth and green initiatives. See why we suggest a hold on ...

Mastercard is a solid long-term investment with strong growth prospects, driven by its global reach and innovative business ...

We recommend holding Adobe stock, with a potential buy opportunity at $350, citing strong cash flow and AI potential. Read an ...

Ares Capital's mix of floating rate debt principal outstanding has been steadily increasing since Q1 FY22. Read why ARCC ...

TSMC's dominance in advanced semiconductor manufacturing positions it as a key player in the AI revolution. Read what makes ...

Gold's recent surge is driven by Chinese demand and concerns about monetary stability. Click here to read why my outlook on ...

Mattr has shifted its focus to specialized, higher-margin sectors, positioning itself for long-term growth. Read what led me ...

DGRW outperformed many dividend ETFs and managed 2022 bear market better than the S&P 500. Read why DGRW is worth considering ...